Sep 6 |
FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 20 |
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
|
Aug 9 |
FibroBiologics GAAP EPS of $0.03 beats by $0.10
|
Aug 7 |
FibroBiologics Files 2024 Second Quarter Report
|
Jul 30 |
IPO Roundup: Pershing Square, Actuate Therapeutics and more
|
Jun 25 |
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
|
Jun 18 |
FibroBiologics files for 16.02M shares of common stock by selling shareholder
|
Jun 6 |
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
|